Overview

Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study evaluated the effect of valsartan on small vessel blood flow in patients with mild-to-moderate hypertension in direct comparison to atenolol and hydrochlorothiazide.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Atenolol
Hydrochlorothiazide
Valsartan